Literature DB >> 23790266

Clinico-radiological spectrum of reversible splenial lesions in children.

Mitsuru Kashiwagi1, Takuya Tanabe2, Shuichi Shimakawa3, Michiko Nakamura4, Shinya Murata5, Kousuke Shabana4, Jun Shinohara4, Yutaka Odanaka6, Hideki Matsumura5, Koh Maki5, Kenichi Okumura5, Keisuke Okasora5, Hiroshi Tamai3.   

Abstract

Recently, many cases of children presenting reversible splenial lesions during febrile illness (RESLEF) have been reported; however, their overall clinico-radiological features are unclear. To describe the clinico-radiological features, we retrospectively reviewed the etiology (pathogen), clinical course, laboratory data, magnetic resonance imaging and electroencephalography (EEG) findings, therapy, and prognosis of 23 episodes in 22 children (1 child recurred) who presented neurological symptoms, with RESLEF. The etiologies (pathogens) varied. Seizure occurred in 7 episodes, disturbance of consciousness (DC) in 13, and delirious behavior in 18. Serum sodium levels <136 mEq/L were observed in 18 episodes. Lesions outside the splenium were found in 4 cases. Slow waves were observed on EEG in 10 episodes. Methylprednisolone pulse therapy was given in 7 cases. No case resulted in neurological sequelae. Among 23 episodes, clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) was diagnosed in 6 episodes, whereas non-MERS was observed in 17 episodes. No difference was observed in almost all the clinico-radiological features' data between the 2 groups. The largest differences were observed in the rate of purposeless movement, DC, extension of the abnormal lesions outside the splenium, and marked slowing of background activity on EEG. RESLEF exhibit a spectrum of clinico-radiological features. These results suggest that non-MERS and MERS both are a part of a larger pathological condition, which we have termed as RESLEF spectrum syndrome. Given the view that such a syndrome exists, the clinical characteristics and position of non-MERS and MERS become clear.
Copyright © 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinically mild encephalitis/encephalopathy; Delirious behavior; Disturbance of consciousness; RESLEF spectrum syndrome; Reversible splenial lesions during febrile illness; Spectrum of clinico-radiological features

Mesh:

Year:  2013        PMID: 23790266     DOI: 10.1016/j.braindev.2013.05.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  20 in total

Review 1.  Reversible splenial lesions presenting in conjunction with febrile illness: a case series and literature review.

Authors:  David Lin; Matthew Rheinboldt
Journal:  Emerg Radiol       Date:  2017-05-18

2.  Reversible lesions of the corpus callosum with initially restricted diffusion in a series of Caucasian children.

Authors:  Anthony Le Bras; Maia Proisy; Mathieu Kuchenbuch; Constantin Gomes; Catherine Tréguier; Sylvia Napuri; Emmanuel Quehen; Bertrand Bruneau
Journal:  Pediatr Radiol       Date:  2018-04-17

3.  Mild encephalopathy/encephalitis with a reversible splenial lesion (MERS): A report of five neonatal cases.

Authors:  Dan Sun; Wen-Hong Chen; Suraj Baralc; Juan Wang; Zhi-Sheng Liu; Yuan-Peng Xia; Lei Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 4.  [Kawasaki disease complicated with mild encephalitis/encephalopathy with a reversible splenial lesion: A case report and literature review].

Authors:  Y Y DU; J Wang; L He; L N Ji; X W Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

5.  Update on benign convulsions with mild gastroenteritis.

Authors:  Yeong Seok Lee; Ga Hee Lee; Young Se Kwon
Journal:  Clin Exp Pediatr       Date:  2021-12-27

6.  Mild encephalitis/encephalopathy with a reversible splenial lesion in children.

Authors:  Adalet Elçin Yıldız; Hülya Maraş Genç; Esra Gürkaş; Havva Akmaz Ünlü; İbrahim Halil Öncel; Alev Güven
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

7.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

8.  Distinguishing Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion from Prolonged Febrile Seizures by Acute Phase EEG Spectrum Analysis.

Authors:  Masayoshi Oguri; Yoshiaki Saito; Chisako Fukuda; Kazuko Kishi; Atsushi Yokoyama; Sooyoung Lee; Hiroyuki Torisu; Mitsuo Toyoshima; Hitoshi Sejima; Shunsaku Kaji; Shin-Ichiro Hamano; Toru Okanishi; Yutaka Tomita; Yoshihiro Maegaki
Journal:  Yonago Acta Med       Date:  2016-04-01       Impact factor: 1.641

9.  Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.

Authors:  Yuanzhao Zhu; Junjun Zheng; Ling Zhang; Zhenguo Zeng; Min Zhu; Xiaobin Li; Xiaoliang Lou; Hui Wan; Daojun Hong
Journal:  BMC Neurol       Date:  2016-04-18       Impact factor: 2.474

10.  Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.